Hannah E. Shaw

Hannah E. Shaw

Auto-generated profile, based on publicly available information

Hannah E. Shaw

Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
JJJared C. James
Jared C. James
JTJessica R. Thrush
Jessica R. Thrush
TYTaher M. Yusufali
Taher M. Yusufali
HSHannah E. Shaw
Hannah E. Shaw
MAMarina Avram
Marina Avram
WFWilliam E. Fantegrossi
William E. Fantegrossi

12 June 2025 in Neuropharmacology
Verified
Journal Article
Closed access
BGBrenda M. Gannon
Brenda M. Gannon
MSMary E. Shepard
Mary E. Shepard
JPJustin M. Pressley
Justin M. Pressley
HSHannah E. Shaw
Hannah E. Shaw
KWKayla J. Wolf
Kayla J. Wolf
WFWilliam E. Fantegrossi
William E. Fantegrossi

17 July 2026 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
MBMichael D. Berquist
Michael D. Berquist
BGBrenda M. Gannon
Brenda M. Gannon
KHKevin M. Honeywell
Kevin M. Honeywell
HSHannah E. Shaw
Hannah E. Shaw
TCTheresa M. Carbonaro
Theresa M. Carbonaro
WFWilliam E. Fantegrossi
William E. Fantegrossi

28 September 2026 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
BGBrenda M. Gannon
Brenda M. Gannon
JPJustin M. Pressley
Justin M. Pressley
AFAndriy Fomin
Andriy Fomin
SRSierra Rowe
Sierra Rowe
HSHannah E. Shaw
Hannah E. Shaw
WFWilliam E. Fantegrossi
William E. Fantegrossi
Over the past 20 years, N-ethyl-methamphetamine (NEM) has been identified in seized methamphetamine (METH) samples. Often considered a byproduct or impurity of illicit METH synthesis, its structural similarity to METH suggests that it may have pharmacological actions of its own or be metabolically converted to METH or amphetamine (AMPH) in vivo. These studies assessed the potency and effectiveness of NEM as a locomotor stimulant compared to METH in NIH Swiss mice, and probed the role of cytochrome P450 (CYP) vs non-CYP metabolism in these locomotor effects using pretreatments with the broad spectrum CYP inhibitor 1-aminobenzotriazole (1-ABT) or the selective CYP2D6 inhibitor quinidine. Blood samples taken from mice treated with NEM, with and without pretreatments of 1-ABT or quinidine, were quantitively analyzed for NEM, METH, and AMPH using Quadrupole Time-of-Flight. Additionally, the discriminative stimulus effects of NEM were assayed in Sprague-Dawley rats trained to discriminate METH from saline. NEM produced dose-dependent locomotor stimulant and METH-like interoceptive effects, but with a slower onset and less potently than METH. Locomotor stimulant effects of NEM were abolished by pretreatment with 1-ABT or quinidine, and both pretreatments also decreased conversion of NEM to METH and AMPH in mouse blood. These data demonstrate METH-like biological effects of NEM and suggest that the likely mechanism for these effects is metabolic conversion of NEM to METH and AMPH via CYP2D6. NEM thus functions as a prodrug for METH and AMPH, and would be expected to have METH-like abuse liability in humans. SIGNIFICANCE STATEMENT: N-ethyl-methamphetamine (NEM) has been identified in seized methamphetamine (METH) samples, and is typically considered a byproduct or impurity of illicit METH synthesis. These studies demonstrate METH-like biological effects of NEM and suggest that the likely mechanism for these effects is metabolic conversion of NEM to METH and AMPH via CYP2D6. NEM thus functions as a prodrug for METH and AMPH, and would be expected to have METH-like abuse liability in humans.